ChartMill assigns a Buy % Consensus number of 80% to AIM. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-03 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-12-10 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-10-22 | Maxim Group | Maintains | Buy -> Buy |
| 2024-09-03 | Ascendiant Capital | Maintains | Buy -> Buy |
5 analysts have analysed AIM and the average price target is 24.48 USD. This implies a price increase of 1510.53% is expected in the next year compared to the current price of 1.52.
The consensus rating for AIM IMMUNOTECH INC (AIM) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering AIM IMMUNOTECH INC (AIM) is 5.